Search results
Showing 16 to 30 of 283 results for covid
CFHealthHub for managing cystic fibrosis during the COVID-19 pandemic (MIB219)
NICE has developed a medtech innovation briefing (MIB) on CFHealthHub for managing cystic fibrosis during the COVID-19 pandemic .
This guideline sets out an antimicrobial prescribing strategy for acute cough associated with an upper respiratory tract infection or acute bronchitis in adults, young people and children. It aims to limit antibiotic use and reduce antibiotic resistance.
In development Reference number: GID-TA11224 Expected publication date: TBC
Awaiting development Reference number: GID-TA11226 Expected publication date: TBC
Awaiting development Reference number: GID-TA11227 Expected publication date: TBC
This quality standard covers the routine antenatal care that women and their babies should receive during pregnancy. It describes high-quality care in priority areas for improvement.
View quality statements for QS22Show all sections
Sections for QS22
- Quality statements
- Quality statement 1: Access to antenatal care
- Quality statement 2: Risk assessment
- Quality statement 3: Continuity of carer
- Quality statement 4: Vaccination
- Quality statement 5: Referral for stop-smoking support and treatment
- Quality statement 6: Healthy eating in pregnancy
- Update information
This guideline covers assessment of people aged 16 and over with symptoms and signs of acute respiratory infection (bacterial or viral) at first remote or in-person contact with NHS services. It also covers the initial management of any infections. It aims to support healthcare practitioners in making sure that people’s treatment follows the best care pathway. It forms part of a suite of work on virtual wards being undertaken by NICE.
Risk of radiotherapy in people with cancer and COVID-19: Are patients with cancer and COVID-19...
risk of new COVID-19 and severity of COVID-19: Does radiation-induced lymphopenia predispose...
Evidence-based recommendations on talquetamab (Talvey) for treating relapsed and refractory multiple myeloma after 3 or more treatments in adults.
systemic anticancer treatment in people with cancer and COVID-19: Are patients with cancer and...
School-based interventions: physical and mental health and wellbeing promotion
In development Reference number: GID-QS10070 Expected publication date: TBC
Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s (NG202)
This guideline covers the diagnosis and management of obstructive sleep apnoea/hypopnoea syndrome (OSAHS), obesity hypoventilation syndrome (OHS) and chronic obstructive pulmonary disease with OSAHS (COPD–OSAHS overlap syndrome) in people over 16. It aims to improve recognition, investigation and treatment of these related conditions.
efficacy and safety of COVID-specific antiviral drugs in combination with other COVID-specific...
CFHealthHub for managing cystic fibrosis during the COVID-19 pandemic
Topic prioritisation